Covid-19 Impact on Global Fabry Disease Treatment Market Size, Status and Forecast 2020-2026
Fabry disease is a rare X-linked lysosomal storage disorder with a deficiency of alpha galactosidase enzyme resulting in progressive organ dysfunction. This disease is caused by abnormal buildup of a specific fatty matter called globotriaosylceramide in multiple tissues of the body including eyes, skin, kidney, gastrointestinal system, brain, heart, and central nervous system.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Fabry Disease Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Fabry Disease Treatment industry.
Based on our recent survey, we have several different scenarios about the Fabry Disease Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1491.8 million in 2019. The market size of Fabry Disease Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fabry Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fabry Disease Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Fabry Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Fabry Disease Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Fabry Disease Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fabry Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fabry Disease Treatment market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Fabry Disease Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Fabry Disease Treatment industry.
Based on our recent survey, we have several different scenarios about the Fabry Disease Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1491.8 million in 2019. The market size of Fabry Disease Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fabry Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fabry Disease Treatment market in terms of revenue.
Players, stakeholders, and other participants in the global Fabry Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Fabry Disease Treatment market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Fabry Disease Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fabry Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fabry Disease Treatment market.
The following players are covered in this report:
- Sanofi S.A.
- Takeda
- Amicus Therapeutics Inc.
- ISU Abxis Co Ltd.
- JCR Pharmaceuticals Co Ltd.
- Protalix Biotherapeutics Inc.
- Idorsia Pharmaceuticals Ltd.
- Avrobio Inc.
- Greenovation Biotech GmbH
- Moderna Therapeutics Inc.
- Green Cross Pharma Pte Ltd.
- Enzyme Replacement Therapy (ERT)
- Chaperone Treatment
- Substrate Reduction Therapy (SRT)
- Others
- Hospital
- Clinic
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Fabry Disease Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Fabry Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Enzyme Replacement Therapy (ERT)
1.4.3 Chaperone Treatment
1.4.4 Substrate Reduction Therapy (SRT)
1.4.5 Others
1.5 Market by Application
1.5.1 Global Fabry Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Fabry Disease Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Fabry Disease Treatment Industry
1.6.1.1 Fabry Disease Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Fabry Disease Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Fabry Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Fabry Disease Treatment Market Perspective (2015-2026)
2.2 Fabry Disease Treatment Growth Trends by Regions
2.2.1 Fabry Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fabry Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Fabry Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Fabry Disease Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Fabry Disease Treatment Players by Market Size
3.1.1 Global Top Fabry Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Fabry Disease Treatment Market Concentration Ratio
3.2.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2019
3.3 Fabry Disease Treatment Key Players Head office and Area Served
3.4 Key Players Fabry Disease Treatment Product Solution and Service
3.5 Date of Enter into Fabry Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2021-2026)
5 FABRY DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Fabry Disease Treatment Market Size by Application (2015-2020)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Fabry Disease Treatment Market Size (2015-2020)
6.2 Fabry Disease Treatment Key Players in North America (2019-2020)
6.3 North America Fabry Disease Treatment Market Size by Type (2015-2020)
6.4 North America Fabry Disease Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Fabry Disease Treatment Market Size (2015-2020)
7.2 Fabry Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Fabry Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Fabry Disease Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Fabry Disease Treatment Market Size (2015-2020)
8.2 Fabry Disease Treatment Key Players in China (2019-2020)
8.3 China Fabry Disease Treatment Market Size by Type (2015-2020)
8.4 China Fabry Disease Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Fabry Disease Treatment Market Size (2015-2020)
9.2 Fabry Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Fabry Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Fabry Disease Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Fabry Disease Treatment Market Size (2015-2020)
10.2 Fabry Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Fabry Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Fabry Disease Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Fabry Disease Treatment Market Size (2015-2020)
11.2 Fabry Disease Treatment Key Players in India (2019-2020)
11.3 India Fabry Disease Treatment Market Size by Type (2015-2020)
11.4 India Fabry Disease Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Fabry Disease Treatment Market Size (2015-2020)
12.2 Fabry Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Fabry Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Fabry Disease Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Details
13.1.2 Sanofi S.A. Business Overview and Its Total Revenue
13.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
13.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2015-2020))
13.1.5 Sanofi S.A. Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview and Its Total Revenue
13.2.3 Takeda Fabry Disease Treatment Introduction
13.2.4 Takeda Revenue in Fabry Disease Treatment Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Amicus Therapeutics Inc.
13.3.1 Amicus Therapeutics Inc. Company Details
13.3.2 Amicus Therapeutics Inc. Business Overview and Its Total Revenue
13.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
13.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.3.5 Amicus Therapeutics Inc. Recent Development
13.4 ISU Abxis Co Ltd.
13.4.1 ISU Abxis Co Ltd. Company Details
13.4.2 ISU Abxis Co Ltd. Business Overview and Its Total Revenue
13.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
13.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
13.4.5 ISU Abxis Co Ltd. Recent Development
13.5 JCR Pharmaceuticals Co Ltd.
13.5.1 JCR Pharmaceuticals Co Ltd. Company Details
13.5.2 JCR Pharmaceuticals Co Ltd. Business Overview and Its Total Revenue
13.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
13.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
13.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
13.6 Protalix Biotherapeutics Inc.
13.6.1 Protalix Biotherapeutics Inc. Company Details
13.6.2 Protalix Biotherapeutics Inc. Business Overview and Its Total Revenue
13.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
13.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.6.5 Protalix Biotherapeutics Inc. Recent Development
13.7 Idorsia Pharmaceuticals Ltd.
13.7.1 Idorsia Pharmaceuticals Ltd. Company Details
13.7.2 Idorsia Pharmaceuticals Ltd. Business Overview and Its Total Revenue
13.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
13.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
13.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
13.8 Avrobio Inc.
13.8.1 Avrobio Inc. Company Details
13.8.2 Avrobio Inc. Business Overview and Its Total Revenue
13.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
13.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.8.5 Avrobio Inc. Recent Development
13.9 Greenovation Biotech GmbH
13.9.1 Greenovation Biotech GmbH Company Details
13.9.2 Greenovation Biotech GmbH Business Overview and Its Total Revenue
13.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
13.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2015-2020)
13.9.5 Greenovation Biotech GmbH Recent Development
13.10 Moderna Therapeutics Inc.
13.10.1 Moderna Therapeutics Inc. Company Details
13.10.2 Moderna Therapeutics Inc. Business Overview and Its Total Revenue
13.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
13.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.10.5 Moderna Therapeutics Inc. Recent Development
13.11 Green Cross Pharma Pte Ltd.
10.11.1 Green Cross Pharma Pte Ltd. Company Details
10.11.2 Green Cross Pharma Pte Ltd. Business Overview and Its Total Revenue
10.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
10.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
10.11.5 Green Cross Pharma Pte Ltd. Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Fabry Disease Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Fabry Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Enzyme Replacement Therapy (ERT)
1.4.3 Chaperone Treatment
1.4.4 Substrate Reduction Therapy (SRT)
1.4.5 Others
1.5 Market by Application
1.5.1 Global Fabry Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Fabry Disease Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Fabry Disease Treatment Industry
1.6.1.1 Fabry Disease Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Fabry Disease Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Fabry Disease Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Fabry Disease Treatment Market Perspective (2015-2026)
2.2 Fabry Disease Treatment Growth Trends by Regions
2.2.1 Fabry Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fabry Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Fabry Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Fabry Disease Treatment Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Fabry Disease Treatment Players by Market Size
3.1.1 Global Top Fabry Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Fabry Disease Treatment Market Concentration Ratio
3.2.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2019
3.3 Fabry Disease Treatment Key Players Head office and Area Served
3.4 Key Players Fabry Disease Treatment Product Solution and Service
3.5 Date of Enter into Fabry Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2021-2026)
5 FABRY DISEASE TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Fabry Disease Treatment Market Size by Application (2015-2020)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Fabry Disease Treatment Market Size (2015-2020)
6.2 Fabry Disease Treatment Key Players in North America (2019-2020)
6.3 North America Fabry Disease Treatment Market Size by Type (2015-2020)
6.4 North America Fabry Disease Treatment Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Fabry Disease Treatment Market Size (2015-2020)
7.2 Fabry Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Fabry Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Fabry Disease Treatment Market Size by Application (2015-2020)
8 CHINA
8.1 China Fabry Disease Treatment Market Size (2015-2020)
8.2 Fabry Disease Treatment Key Players in China (2019-2020)
8.3 China Fabry Disease Treatment Market Size by Type (2015-2020)
8.4 China Fabry Disease Treatment Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Fabry Disease Treatment Market Size (2015-2020)
9.2 Fabry Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Fabry Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Fabry Disease Treatment Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Fabry Disease Treatment Market Size (2015-2020)
10.2 Fabry Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Fabry Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Fabry Disease Treatment Market Size by Application (2015-2020)
11 INDIA
11.1 India Fabry Disease Treatment Market Size (2015-2020)
11.2 Fabry Disease Treatment Key Players in India (2019-2020)
11.3 India Fabry Disease Treatment Market Size by Type (2015-2020)
11.4 India Fabry Disease Treatment Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Fabry Disease Treatment Market Size (2015-2020)
12.2 Fabry Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Fabry Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Fabry Disease Treatment Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Sanofi S.A.
13.1.1 Sanofi S.A. Company Details
13.1.2 Sanofi S.A. Business Overview and Its Total Revenue
13.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
13.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2015-2020))
13.1.5 Sanofi S.A. Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview and Its Total Revenue
13.2.3 Takeda Fabry Disease Treatment Introduction
13.2.4 Takeda Revenue in Fabry Disease Treatment Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Amicus Therapeutics Inc.
13.3.1 Amicus Therapeutics Inc. Company Details
13.3.2 Amicus Therapeutics Inc. Business Overview and Its Total Revenue
13.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
13.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.3.5 Amicus Therapeutics Inc. Recent Development
13.4 ISU Abxis Co Ltd.
13.4.1 ISU Abxis Co Ltd. Company Details
13.4.2 ISU Abxis Co Ltd. Business Overview and Its Total Revenue
13.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
13.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
13.4.5 ISU Abxis Co Ltd. Recent Development
13.5 JCR Pharmaceuticals Co Ltd.
13.5.1 JCR Pharmaceuticals Co Ltd. Company Details
13.5.2 JCR Pharmaceuticals Co Ltd. Business Overview and Its Total Revenue
13.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
13.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
13.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
13.6 Protalix Biotherapeutics Inc.
13.6.1 Protalix Biotherapeutics Inc. Company Details
13.6.2 Protalix Biotherapeutics Inc. Business Overview and Its Total Revenue
13.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
13.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.6.5 Protalix Biotherapeutics Inc. Recent Development
13.7 Idorsia Pharmaceuticals Ltd.
13.7.1 Idorsia Pharmaceuticals Ltd. Company Details
13.7.2 Idorsia Pharmaceuticals Ltd. Business Overview and Its Total Revenue
13.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
13.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
13.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
13.8 Avrobio Inc.
13.8.1 Avrobio Inc. Company Details
13.8.2 Avrobio Inc. Business Overview and Its Total Revenue
13.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
13.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.8.5 Avrobio Inc. Recent Development
13.9 Greenovation Biotech GmbH
13.9.1 Greenovation Biotech GmbH Company Details
13.9.2 Greenovation Biotech GmbH Business Overview and Its Total Revenue
13.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
13.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2015-2020)
13.9.5 Greenovation Biotech GmbH Recent Development
13.10 Moderna Therapeutics Inc.
13.10.1 Moderna Therapeutics Inc. Company Details
13.10.2 Moderna Therapeutics Inc. Business Overview and Its Total Revenue
13.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
13.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020)
13.10.5 Moderna Therapeutics Inc. Recent Development
13.11 Green Cross Pharma Pte Ltd.
10.11.1 Green Cross Pharma Pte Ltd. Company Details
10.11.2 Green Cross Pharma Pte Ltd. Business Overview and Its Total Revenue
10.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
10.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2015-2020)
10.11.5 Green Cross Pharma Pte Ltd. Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Fabry Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Fabry Disease Treatment Revenue
Table 3. Ranking of Global Top Fabry Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Fabry Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enzyme Replacement Therapy (ERT)
Table 6. Key Players of Chaperone Treatment
Table 7. Key Players of Substrate Reduction Therapy (SRT)
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Fabry Disease Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Fabry Disease Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Fabry Disease Treatment Players to Combat Covid-19 Impact
Table 14. Global Fabry Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Fabry Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Fabry Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Fabry Disease Treatment Market Share by Regions (2015-2020)
Table 18. Global Fabry Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Fabry Disease Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Fabry Disease Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Fabry Disease Treatment Players
Table 25. Global Fabry Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Fabry Disease Treatment Market Share by Players (2015-2020)
Table 27. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Treatment as of 2019)
Table 28. Global Fabry Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Fabry Disease Treatment Product Solution and Service
Table 31. Date of Enter into Fabry Disease Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Fabry Disease Treatment Market Size Share by Type (2015-2020)
Table 35. Global Fabry Disease Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Fabry Disease Treatment Market Size Share by Application (2015-2020)
Table 37. Global Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Fabry Disease Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 41. North America Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Fabry Disease Treatment Market Share by Type (2015-2020)
Table 43. North America Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Fabry Disease Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 47. Europe Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Fabry Disease Treatment Market Share by Type (2015-2020)
Table 49. Europe Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Fabry Disease Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 53. China Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Fabry Disease Treatment Market Share by Type (2015-2020)
Table 55. China Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Fabry Disease Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 59. Japan Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Fabry Disease Treatment Market Share by Type (2015-2020)
Table 61. Japan Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Fabry Disease Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 65. Southeast Asia Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Fabry Disease Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Fabry Disease Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 71. India Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Fabry Disease Treatment Market Share by Type (2015-2020)
Table 73. India Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Fabry Disease Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 77. Central & South America Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Fabry Disease Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Fabry Disease Treatment Market Share by Application (2015-2020)
Table 81. Sanofi S.A. Company Details
Table 82. Sanofi S.A. Business Overview
Table 83. Sanofi S.A. Product
Table 84. Sanofi S.A. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 85. Sanofi S.A. Recent Development
Table 86. Takeda Company Details
Table 87. Takeda Business Overview
Table 88. Takeda Product
Table 89. Takeda Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 90. Takeda Recent Development
Table 91. Amicus Therapeutics Inc. Company Details
Table 92. Amicus Therapeutics Inc. Business Overview
Table 93. Amicus Therapeutics Inc. Product
Table 94. Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 95. Amicus Therapeutics Inc. Recent Development
Table 96. ISU Abxis Co Ltd. Company Details
Table 97. ISU Abxis Co Ltd. Business Overview
Table 98. ISU Abxis Co Ltd. Product
Table 99. ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 100. ISU Abxis Co Ltd. Recent Development
Table 101. JCR Pharmaceuticals Co Ltd. Company Details
Table 102. JCR Pharmaceuticals Co Ltd. Business Overview
Table 103. JCR Pharmaceuticals Co Ltd. Product
Table 104. JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 105. JCR Pharmaceuticals Co Ltd. Recent Development
Table 106. Protalix Biotherapeutics Inc. Company Details
Table 107. Protalix Biotherapeutics Inc. Business Overview
Table 108. Protalix Biotherapeutics Inc. Product
Table 109. Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 110. Protalix Biotherapeutics Inc. Recent Development
Table 111. Idorsia Pharmaceuticals Ltd. Company Details
Table 112. Idorsia Pharmaceuticals Ltd. Business Overview
Table 113. Idorsia Pharmaceuticals Ltd. Product
Table 114. Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 115. Idorsia Pharmaceuticals Ltd. Recent Development
Table 116. Avrobio Inc. Business Overview
Table 117. Avrobio Inc. Product
Table 118. Avrobio Inc. Company Details
Table 119. Avrobio Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 120. Avrobio Inc. Recent Development
Table 121. Greenovation Biotech GmbH Company Details
Table 122. Greenovation Biotech GmbH Business Overview
Table 123. Greenovation Biotech GmbH Product
Table 124. Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 125. Greenovation Biotech GmbH Recent Development
Table 126. Moderna Therapeutics Inc. Company Details
Table 127. Moderna Therapeutics Inc. Business Overview
Table 128. Moderna Therapeutics Inc. Product
Table 129. Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 130. Moderna Therapeutics Inc. Recent Development
Table 131. Green Cross Pharma Pte Ltd. Company Details
Table 132. Green Cross Pharma Pte Ltd. Business Overview
Table 133. Green Cross Pharma Pte Ltd. Product
Table 134. Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 135. Green Cross Pharma Pte Ltd. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 1. Fabry Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Fabry Disease Treatment Revenue
Table 3. Ranking of Global Top Fabry Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Fabry Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Enzyme Replacement Therapy (ERT)
Table 6. Key Players of Chaperone Treatment
Table 7. Key Players of Substrate Reduction Therapy (SRT)
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Fabry Disease Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Fabry Disease Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Fabry Disease Treatment Players to Combat Covid-19 Impact
Table 14. Global Fabry Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Fabry Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Fabry Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Fabry Disease Treatment Market Share by Regions (2015-2020)
Table 18. Global Fabry Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Fabry Disease Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Fabry Disease Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Fabry Disease Treatment Players
Table 25. Global Fabry Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Fabry Disease Treatment Market Share by Players (2015-2020)
Table 27. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Treatment as of 2019)
Table 28. Global Fabry Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Fabry Disease Treatment Product Solution and Service
Table 31. Date of Enter into Fabry Disease Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Fabry Disease Treatment Market Size Share by Type (2015-2020)
Table 35. Global Fabry Disease Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Fabry Disease Treatment Market Size Share by Application (2015-2020)
Table 37. Global Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Fabry Disease Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 41. North America Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Fabry Disease Treatment Market Share by Type (2015-2020)
Table 43. North America Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Fabry Disease Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 47. Europe Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Fabry Disease Treatment Market Share by Type (2015-2020)
Table 49. Europe Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Fabry Disease Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 53. China Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Fabry Disease Treatment Market Share by Type (2015-2020)
Table 55. China Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Fabry Disease Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 59. Japan Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Fabry Disease Treatment Market Share by Type (2015-2020)
Table 61. Japan Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Fabry Disease Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 65. Southeast Asia Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Fabry Disease Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Fabry Disease Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 71. India Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Fabry Disease Treatment Market Share by Type (2015-2020)
Table 73. India Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Fabry Disease Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Fabry Disease Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Fabry Disease Treatment Market Share (2019-2020)
Table 77. Central & South America Fabry Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Fabry Disease Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Fabry Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Fabry Disease Treatment Market Share by Application (2015-2020)
Table 81. Sanofi S.A. Company Details
Table 82. Sanofi S.A. Business Overview
Table 83. Sanofi S.A. Product
Table 84. Sanofi S.A. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 85. Sanofi S.A. Recent Development
Table 86. Takeda Company Details
Table 87. Takeda Business Overview
Table 88. Takeda Product
Table 89. Takeda Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 90. Takeda Recent Development
Table 91. Amicus Therapeutics Inc. Company Details
Table 92. Amicus Therapeutics Inc. Business Overview
Table 93. Amicus Therapeutics Inc. Product
Table 94. Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 95. Amicus Therapeutics Inc. Recent Development
Table 96. ISU Abxis Co Ltd. Company Details
Table 97. ISU Abxis Co Ltd. Business Overview
Table 98. ISU Abxis Co Ltd. Product
Table 99. ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 100. ISU Abxis Co Ltd. Recent Development
Table 101. JCR Pharmaceuticals Co Ltd. Company Details
Table 102. JCR Pharmaceuticals Co Ltd. Business Overview
Table 103. JCR Pharmaceuticals Co Ltd. Product
Table 104. JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 105. JCR Pharmaceuticals Co Ltd. Recent Development
Table 106. Protalix Biotherapeutics Inc. Company Details
Table 107. Protalix Biotherapeutics Inc. Business Overview
Table 108. Protalix Biotherapeutics Inc. Product
Table 109. Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 110. Protalix Biotherapeutics Inc. Recent Development
Table 111. Idorsia Pharmaceuticals Ltd. Company Details
Table 112. Idorsia Pharmaceuticals Ltd. Business Overview
Table 113. Idorsia Pharmaceuticals Ltd. Product
Table 114. Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 115. Idorsia Pharmaceuticals Ltd. Recent Development
Table 116. Avrobio Inc. Business Overview
Table 117. Avrobio Inc. Product
Table 118. Avrobio Inc. Company Details
Table 119. Avrobio Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 120. Avrobio Inc. Recent Development
Table 121. Greenovation Biotech GmbH Company Details
Table 122. Greenovation Biotech GmbH Business Overview
Table 123. Greenovation Biotech GmbH Product
Table 124. Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 125. Greenovation Biotech GmbH Recent Development
Table 126. Moderna Therapeutics Inc. Company Details
Table 127. Moderna Therapeutics Inc. Business Overview
Table 128. Moderna Therapeutics Inc. Product
Table 129. Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 130. Moderna Therapeutics Inc. Recent Development
Table 131. Green Cross Pharma Pte Ltd. Company Details
Table 132. Green Cross Pharma Pte Ltd. Business Overview
Table 133. Green Cross Pharma Pte Ltd. Product
Table 134. Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2015-2020) (Million US$)
Table 135. Green Cross Pharma Pte Ltd. Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Fabry Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Enzyme Replacement Therapy (ERT) Features
Figure 3. Chaperone Treatment Features
Figure 4. Substrate Reduction Therapy (SRT) Features
Figure 5. Others Features
Figure 6. Global Fabry Disease Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Fabry Disease Treatment Report Years Considered
Figure 11. Global Fabry Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Fabry Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Fabry Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Fabry Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2019
Figure 18. North America Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sanofi S.A. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 29. Amicus Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Amicus Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 31. ISU Abxis Co Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ISU Abxis Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 33. JCR Pharmaceuticals Co Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 35. Protalix Biotherapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Protalix Biotherapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 37. Idorsia Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Idorsia Pharmaceuticals Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 39. Avrobio Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Avrobio Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 41. Greenovation Biotech GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Greenovation Biotech GmbH Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 43. Moderna Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Moderna Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 45. Green Cross Pharma Pte Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Green Cross Pharma Pte Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Figure 1. Global Fabry Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Enzyme Replacement Therapy (ERT) Features
Figure 3. Chaperone Treatment Features
Figure 4. Substrate Reduction Therapy (SRT) Features
Figure 5. Others Features
Figure 6. Global Fabry Disease Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Fabry Disease Treatment Report Years Considered
Figure 11. Global Fabry Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Fabry Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Fabry Disease Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Fabry Disease Treatment Market Share by Players in 2019
Figure 16. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fabry Disease Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2019
Figure 18. North America Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Fabry Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Sanofi S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sanofi S.A. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 27. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Takeda Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 29. Amicus Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Amicus Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 31. ISU Abxis Co Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. ISU Abxis Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 33. JCR Pharmaceuticals Co Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 35. Protalix Biotherapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Protalix Biotherapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 37. Idorsia Pharmaceuticals Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Idorsia Pharmaceuticals Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 39. Avrobio Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Avrobio Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 41. Greenovation Biotech GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Greenovation Biotech GmbH Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 43. Moderna Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Moderna Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 45. Green Cross Pharma Pte Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Green Cross Pharma Pte Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
